Hizentra 4 (Immune Globulin Vials) 4g/20ml

HIZENTRA 4 is an immune globulin therapy delivered in ready-to-use vials, designed to support immune system function. This 4g/20ml formulation is commonly used for immunoglobulin replacement in adults and children. Ideal for subcutaneous administration, it provides a convenient option for at-home therapy.

Strength

4g/20ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Csl Behring Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Immune globulin therapy like HIZENTRA 4 is used to treat primary immunodeficiency disorders in patients who cannot produce sufficient antibodies. It may also be prescribed for certain autoimmune conditions where the immune system requires modulation. This therapy helps reduce the frequency of infections by providing passive immunity through concentrated immunoglobulins.

Side Effects

HIZENTRA 4 works by supplying antibodies that help strengthen the body’s immune response. Users may experience improved resistance to common infections and reduced severity of symptoms. Some individuals report a general sense of well-being following regular administration, though individual responses vary.

Precautions & Warnings

Store HIZENTRA 4 at room temperature and protect it from direct sunlight. Always check the vial for particles or discoloration before use. Follow your healthcare provider’s instructions for proper handling and disposal. Keep out of reach of children and pets to prevent accidental exposure.

Avoid Interactions

Immune globulin products like HIZENTRA 4 may interact with live vaccines, potentially reducing their effectiveness. Avoid receiving vaccines for at least 3 months after treatment unless directed by a healthcare professional. Discuss all current medications with your doctor to identify potential interactions.

Frequently Asked Questions

HIZENTRA 4 is used to treat primary immunodeficiency disorders and certain autoimmune conditions by providing passive immunity through immunoglobulin replacement.

HIZENTRA 4 is administered subcutaneously, typically at home under medical supervision for the first use.

Common side effects may include redness or swelling at the injection site, headache, or fatigue. Always report persistent symptoms to a healthcare provider.

Consult a healthcare provider before using HIZENTRA 4 if pregnant or breastfeeding to assess potential risks and benefits.

HIZENTRA 4 is available through licensed pharmacies and specialty suppliers with a valid prescription.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.